Search Results - David Liebowitz

Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults by Kwadwo Ansah Koram, Kathleen A. Walker, Bonaventure Orizu, Idania Marrero, Jean Boyer, ShuPing Yang, Kate E. Broderick, Kwadwo Asamoah Kusi, Eric Kyei-Baafour, Ebenezer Addo Ofori, Abigail Pobee, Susan Adu-Amankwah, Mary Amoakoh-Coleman, Hannah Brown Amoakoh, Hannah Brown Amoakoh, Benjamin Abuaku, Edem Badji, Michael Ntiri, Lydia Quaye, Matthew P. Morrow, Albert J. Sylvester, Emma L. Reuschel, Elisabeth Gillespie, David Liebowitz, Laurent M. Humeau

Get full text